Do you want to read an article? Please log in or register.
Type I and Type III Interferons - Induction, Signaling, Evasion, and Application to Combat COVID-19
Viral Infections, Non-HIV
Related content
Viral Infections, Non-HIV
Type 1 interferons as a potential treatment against COVID-19
Antiviral Res.
Sallard E, Lescure FX, Yazdanpanah Y, Mentre F, Peiffer-Smadja N, C-20-15 DisCoVeRy French Steering Committee.
doi: 10.1016/j.antiviral.2020.104791.
RECOMMENDED
Viral Infections, Non-HIV
Plasma Exchange to Rescue Patients with Autoantibodies Against Type I Interferons and Life-Threatening COVID-19 Pneumonia
★ 2
Recommended by
Dr Martin Frey, Faculty Member
★ 1
Recommended by
Dr Marcus Hesse, Faculty Member
J Clin Immunol
de Prost N, Bastard P, Arrestier R, Fourati S, Mahévas M, Burrel S, Dorgham K, Gorochov G, Tandjaoui-Lambiotte Y, Azzaoui I, Fernandes I, Combes A, Casanova JL, Mekontso-Dessap A, Luyt CE
doi: 10.1007/s10875-021-00994-9
Viral Infections, Non-HIV
Safety, tolerability, and immunogenicity of a recombinant adenovirus type-5 vectored COVID-19 vaccine: a dose-escalation, open-label, non-randomised, first-in-human trial
Lancet.
Zhu FC, Li YH, Guan XH, Hou LH, Wang WJ, Li JX, Wu SP, Wang BS, Wang Z, Wang L, Jia SY, Jiang HD, Wang L, Jiang T, Hu Y, Gou JB, Xu SB, Xu JJ, Wang XW, Wang W, Chen W
doi: 10.1016/S0140-6736(20)31208-3.
Viral Infections, Non-HIV
Immunogenicity and safety of a recombinant adenovirus type-5-vectored COVID-19 vaccine in healthy adults aged 18 years or older: a randomised, double-blind, placebo-controlled, phase 2 trial
Lancet.
Zhu FC, Guan XH, Li YH, Huang JY, Jiang T, Hou LH, Li JX, Yang BF, Wang L, Wang WJ, Wu SP, Wang Z, Wu XH, Xu JJ, Zhang Z, Jia SY, Wang BS, Hu Y, Liu JJ, Zhang J, Qian XA, Li Q, Pan HX, Jiang HD, Deng P, Gou JB, Wang XW, Wang XH, Chen W
doi: 10.1016/S0140-6736(20)31605-6.
Viral Infections, Non-HIV
Renin-Angiotensin system inhibitors effect before and during hospitalization in COVID-19 outcomes: final analysis of the international HOPE COVID-19 (Health Outcome Predictive Evaluation for COVID-19) Registry
Am Heart J
Núñez-Gil IJ, Olier I, Feltes G, Viana-Llamas MC, Maroun-Eid C, Romero R, Fernández-Rozas I, Uribarri A, Becerra-Muñoz VM, Alfonso-Rodriguez E, García-Aguado M, Elola J, Castro-Mejía A, Pepe M, Garcia-Prieto JF, Gonzalez A, Ugo F, Cerrato E, Bondia E, Raposeiras S, Mendez JLJ, Espejo C, Masjuan ÁL, Marin F, López-Pais J, Abumayyaleh M, Corbi-Pascual M, Liebetrau C, Ramakrisna H, Estrada V, Macaya C, HOPE COVID-19 investigators (Cols appendix).
doi: 10.1016/j.ahj.2021.04.001
Viral Infections, Non-HIV
Incidental COVID-19 related lung apical findings on stroke CTA during the COVID-19 pandemic
J Neurointerv Surg.
Kihira S, Schefflein J, Chung M, Mahmoudi K, Rigney B, Delman BN, Mocco J, Doshi A, Belani P
doi: 10.1136/neurintsurg-2020-016188.
Viral Infections, Non-HIV
A complex COVID-19 case with rheumatoid arthritis treated with tocilizumab
Clin Rheumatol.
Cai S, Sun W, Li M, Dong L
doi: 10.1007/s10067-020-05234-w.
Viral Infections, Non-HIV
Repurposed immunomodulatory drugs for Covid-19 in pre-ICu patients - mulTi-Arm Therapeutic study in pre-ICu patients admitted with Covid-19 - Repurposed Drugs (TACTIC-R): A structured summary of a study protocol for a randomised controlled trial
Trials.
Kulkarni S, Fisk M, Kostapanos M, Banham-Hall E, Bond S, Hernan-Sancho E, Norton S, Cheriyan J, Cope A, Galloway J, Hall F, Jayne D, Wilkinson IB
doi: 10.1186/s13063-020-04535-4.
Viral Infections, Non-HIV
Relationship between ABO blood group distribution and clinical characteristics in patients with COVID-19
Clin Chim Acta.
Wu Y, Feng Z, Li P, Yu Q
doi: 10.1016/j.cca.2020.06.026.